Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference
Lifecore Biomedical (NASDAQ: LFCR), a fully integrated contract development and manufacturing organization (CDMO), has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The conference is scheduled to take place from January 13-16, 2025, in San Francisco, California.
The company's management team, including Paul Josephs, chief executive officer, and Ryan Lake, chief financial officer, will be conducting one-on-one meetings during the conference. This participation represents an important opportunity for Lifecore to engage with healthcare industry stakeholders and investors.
Lifecore Biomedical (NASDAQ: LFCR), un'organizzazione completamente integrata per lo sviluppo e la produzione a contratto (CDMO), ha annunciato la sua partecipazione alla 43ª Conferenza Annuale J.P. Morgan Healthcare. La conferenza si svolgerà dal 13 al 16 gennaio 2025, a San Francisco, California.
Il team di gestione dell'azienda, compresi Paul Josephs, amministratore delegato, e Ryan Lake, direttore finanziario, condurrà incontri individuali durante la conferenza. Questa partecipazione rappresenta un'importante opportunità per Lifecore di interagire con i soggetti interessati del settore sanitario e con gli investitori.
Lifecore Biomedical (NASDAQ: LFCR), una organización completamente integrada de desarrollo y fabricación por contrato (CDMO), ha anunciado su participación en la 43ª Conferencia Anual J.P. Morgan Healthcare. La conferencia está programada para llevarse a cabo del 13 al 16 de enero de 2025, en San Francisco, California.
El equipo de dirección de la empresa, incluyendo a Paul Josephs, director ejecutivo, y Ryan Lake, director financiero, llevará a cabo reuniones individuales durante la conferencia. Esta participación representa una importante oportunidad para que Lifecore se relacione con las partes interesadas de la industria de la salud y con los inversores.
라이프코어 바이오메디칼 (NASDAQ: LFCR), 완전히 통합된 계약 개발 및 제조 조직 (CDMO)은 제43회 JP모건 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 이 컨퍼런스는 2025년 1월 13일부터 16일까지 캘리포니아 샌프란시스코에서 열릴 예정입니다.
회사의 경영진, 특히 폴 조셉스 CEO와 라이언 레이크 CFO가 컨퍼런스 동안 일대일 회의를 진행할 것입니다. 이번 참여는 라이프코어가 의료 산업 이해관계자 및 투자자들과 소통할 수 있는 중요한 기회를 제공합니다.
Lifecore Biomedical (NASDAQ: LFCR), une organisation entièrement intégrée de développement et de fabrication sous contrat (CDMO), a annoncé sa participation à la 43e Conférence Annuelle J.P. Morgan Healthcare. La conférence est prévue du 13 au 16 janvier 2025, à San Francisco, Californie.
L'équipe dirigeante de l'entreprise, y compris Paul Josephs, président-directeur général, et Ryan Lake, directeur financier, tiendra des réunions individuelles pendant la conférence. Cette participation représente une opportunité importante pour Lifecore d'engager le dialogue avec les acteurs de l'industrie de la santé et les investisseurs.
Lifecore Biomedical (NASDAQ: LFCR), eine vollständig integrierte Contract Development and Manufacturing Organization (CDMO), hat ihre Teilnahme an der 43. J.P. Morgan Healthcare Conference bekannt gegeben. Die Konferenz findet vom 13. bis 16. Januar 2025 in San Francisco, Kalifornien, statt.
Das Management-Team des Unternehmens, darunter Paul Josephs, CEO, und Ryan Lake, CFO, wird während der Konferenz Einzelgespräche führen. Diese Teilnahme stellt eine wichtige Gelegenheit für Lifecore dar, mit Interessenvertretern der Gesundheitsbranche und Investoren in Kontakt zu treten.
- None.
- None.
CHASKA, Minn., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 43rd Annual J.P. Morgan Healthcare Conference. The conference will take place January 13-16, 2025, in San Francisco, California.
Details regarding Lifecore’s participation are as follows:
- 43rd Annual J.P. Morgan Healthcare Conference
Details: Lifecore management, including Paul Josephs, chief executive officer, and Ryan Lake, chief financial officer, will participate in 1-on-1 meetings
Conference Dates: January 13-16, 2025
Location: San Francisco, California
About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.
FAQ
When is Lifecore Biomedical (LFCR) participating in the J.P. Morgan Healthcare Conference 2025?
Which Lifecore Biomedical (LFCR) executives are attending the 2025 J.P. Morgan Healthcare Conference?
What type of meetings will Lifecore Biomedical (LFCR) conduct at the J.P. Morgan Healthcare Conference 2025?
Where is the 43rd J.P. Morgan Healthcare Conference featuring Lifecore Biomedical (LFCR) being held?
